GlassScriptPhysician profile
Megan Smith
NPI 1518300391
$2,166.82
in general payments reported to CMS, 2019-2025
23 companies · $623 in 2025
The $623 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $110 · 2021: $148 · 2022: $154 · 2023: $309 · 2024: $627 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,046 · Food and Beverage: $413 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,046.25 |
| Food and Beverage | $412.69 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,095.37 | 2023-2025 | Da Vinci Surgical System |
| Astellas Pharma US INC | $277.67 | 2019-2025 | Veozah, Myrbetriq |
| Organon LLC | $138.84 | 2021-2025 | Nexplanon |
| Channel Medsystems, INC. | $74.99 | 2023 | |
| Allergan, INC. | $67.34 | 2019-2020 | |
| Abbvie INC. | $67.26 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $65.09 | 2019-2021 | |
| Daiichi Sankyo INC. | $64.05 | 2019-2020 | |
| Pfizer INC. | $41.61 | 2021-2023 | |
| Therapeuticsmd, INC. | $38.59 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $28.12 | 2020-2021 | |
| Roche Diagnostics Corporation | $25.89 | 2019 | |
| Novo Nordisk INC | $25.82 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.98 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.45 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $16.35 | 2022 | |
| Boston Scientific Corporation | $15.55 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $15.30 | 2021 | |
| Baxter Healthcare | $15.15 | 2020 | |
| Exeltis, USA INC. | $15.13 | 2025 | Slynd |
| Amgen INC. | $14.88 | 2022 | |
| Lilly USA, LLC | $13.81 | 2020 | |
| Minerva Surgical, INC | $12.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.